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PRETERM LABOUR - IS 
MYCOPLASMA HOMINIS 
INVOLVED? 
H J Odendaal, I Popov, J Schoeman, D Grove 
Objective. To assess whether Mycoplasma hominis is associated 
with preterm labour in primigravidae and multigravidae 
with previous midtrimester abortion or preterm labour. 
Design. Cohort analytical study. 
Setting. Tygerberg Hospital, a tertiary academic hospital 
in the Western Cape. 
Methods. Gram's stains were done on smears taken from the 
posterior vaginal fornix, at the first antenatal visit, between 
16 and 26 weeks' gestation, in primigravidae and 
multigravidae at risk for preterm labour. Cultures for M. 
hominis and other commonly occurring organisms were done 
·from endocervical swabs taken at the same visit. The 
outcome of pregnancy in mothers with positive cultures for 
M. hominis was then compared with outcome in women with 
negative cultures. 
Outcome measures. Prevalence of Chlamydia trachomatis, 
Ureaplasma urealyticum, bacterial vaginosis and preterm 
delivery, birth weight and perinatal deaths. 
Results. Cultures for M. hominis were positive in 83 patients 
(21 %) and negative in 312 (79%). Significantly more mothers 
in the positive group (40%) delivered before 37 weeks' 
gestation than in the negative group (28%, P = 0.0313). Their 
babies weighed significantly less (2 669 g v. 2 864 g, P = 
0.0141). The positive group was also associated with more 
alcohol use in pregnancy and fewer of them were married. C. 
trachomatis was found in 18% of mothers in the positive 
group but in 8% of the negative group (P = 0.0082). 
U. urealyticum was cultured in 96% of mothers in the positive 
group in contrast to 81 % in the negative group (P = 0.001). 
Bacterial vaginosis was observed on 75% of mothers with 
positive cultures for M. hominis but in 22% with negative 
cultures (P = 0.00001, odds ratio 10.21, 95% confidence 
interval: 5.63 - 18.65). 
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Conclusion. Positive culture for M. hominis was associated 
with more preterm deliveries and also with a higher 
frequency of C. trachomatis, U. urealyticum and bacterial 
vaginosis. 
S Afr Med J 2002; 92: 235-237. 
Preterm labour is the major cause of perinatal mortality at 
Tygerberg HospitaP and a common indication for expensive 
neonatal intensive care.' It is also a major cause of neonatal 
handicap. It has been found that 11 - 67% of newborns who 
weighed less than 800 g and survived the neonatal period have 
major neurological sequelae.3 The prevalence of preterm 
delivery, according to a community-based study in the 
Tygerberg area, is 20.3% (Tygerberg Hospital Obstetric 
Database - unpublished data). This is very high indeed when 
compared with the 4 - 9.3% prevalence in developed countries.4 
It is therefore essential to determine possible causes of preterm 
labour. 
METHODS 
This study is an extension of a previous randomised controlled 
trial5 where primigravidae and multigravidae at risk for 
preterm labour were screened for bacterial vaginosis (BV) and 
where mothers with BV were treated with either metronidazole 
or 100 mg vitamin Casa placebo. From May 1996 to December 
1996, 426 primigravidae or mothers who had had a previous 
preterm labour or midtrimester miscarriage were recruited at 
the first antenatal visit. Duration of pregnancy at entry to the 
study was limited to between 16 and 26 weeks. Patients with 
multiple pregnancies or known cervical incompetence were 
excluded from the study. Patients who gave a history of taking 
any antibiotics within the previous 2 weeks were not 
immediately enrolled but were seen 2 weeks after they had 
completed the course, providing that they were still less than 
26 weeks pregnant. 
After informed consent was obtained for the study a general 
examination was done followed by a speculum examination. 
Using an Ayer's spatula a posterior fornix smear was taken for 
a Gram's stain and a wet mount examination/amine test. For 
the latter a 10% potassium hydroxide solution was used.6 The 
wet mount smear was immediately evaluated for prevalence of 
lactobacilli, clue cells, Candida albicans and Trichomonas 
vaginalis. The other slide was flame-dried, Gram-stained (using lflD 
carbolfuchsin as the counter stain) and immediately examined 
for lactobacilli, clue cells, C. albicans and Mobiluncus spp. The 
presence of lactobacilli and clue cells was scored as described 
by Spiegel et al.7 to diagnose BV. Two swabs were taken from 
the endocervix for investigation for Chlamydia trachomatis, 
Mycoplasma hominis and Ureaplasma urealyticum. These smears 
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were immediately placed in a Mastazyme-Chlamydia transport 
medium (Davies Diagnostics Pty Ltd, Table View, Cape Town) 
and Mycoplasma broth transport medium (Microbiology 
Department, Tygerberg Hospital), respectively. 
Swabs were then immediately sent to the laboratory for 
enzyme immunoassay of Chlamydia antigens and culture of M. 
hominis and U. urealyticum. Specimens for the latter cultures 
were stored at -6°C for later examination. Specimens were then 
defrosted and the swabs were vortexed in the Mycoplasma 
broth. Of the Mycoplasma broth 0.5 ml was subcultured into 
fresh Mycoplasma broth and 0.5 ml into Ureaplasma broth 
respectively and incubated at 37°C aerobically for 20 hours. 
Thereafter 0.5 ml of the Mycoplasma broth was subcultured into 
'A broth' (for subculture of M. hominis) and 0.5 ml of the 
Ureaplasma broth into fresh Ureaplasma broth. This was 
incubated aerobically at 37°C for 48 hours. No change in colour 
indicated negative growth, a pink colour in the 'A broth' 
indicated positive growth for M. hominis and pink in the 
Ureaplasma broth positive growth for U. urealyticum.' 
Ultrasound examinations were done to confirm the 
gestational age when the estimated gestational age was less 
than 24 weeks, to locate the placenta, measure the cervical 
length and exclude beaking of the internal cervical os. The 
bi parietal diameter was used to determine the gestational age 
or, after 24 weeks, the last normal menstruation or clinical 
estimation of the fundal height. 
After 4 weeks patients who had BV at the first examination 
had repeat vaginal smears to assess response to the therapy. If 
BV was again found, another 2-day course of the same drug, as 
given previously, was prescribed. Patients were followed up 
for the outcome of the pregnancy. Mothers who were M. 
hominis-positive were then compared with.those with negative 
cultures regarding obstetric history, pregnancy outcome and 
presence of BV. 
The chi-square test with Yates' correction was used to test the 
significance of the differences between the different groups. 
Continuous variables were compared with the Student's t-test 
using the Statgraphics and Epi 6 statistical software 
programme. 
RESULTS 
A total of 426 patients were invited to participate in the study. 
Thirty-one were excluded because laboratory results were lost, 
inclusion criteria were not met, information on labour was 
lacking and for various other reasons. Data on 395 patients 
were analysed, with 21 % having positive cultures for 
M. hominis (Fig. 1). 
The two groups were comparable regarding obstetric history 
except for significantly more unmarried mothers and alcohol 
use in the Mycoplasma group (Table I). 
Significantly more mothers in the Mycoplasma group 
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426 patients recruited 
· 31 excluded from study 
.395 analysed 
M. hominis-positive M. hominis-negative 
I 
83 (21%)* 312 (79%)+ 
I 
33 < 37 weeks ( 40%) 50 ;,, 37 weeks 86 < 37 weeks (28%) 226;,, 37 weeks 
* One patient delivered before 22 weeks. 
+ Six patients delivered before 22 weeks. 
Fig. 1. Study profile. 
Table I. Obstetdc history for women in the Mycoplasma-positive 
and negative groups 
M1!.coplasma+ Mycoplasma- P-value 
Number of patients(%) 83 (21) 312 (79) 
Mean age (years) (SD) 24.2 (5.9) 25.3 (6.4) 0.1795 
Married(%) 22 (27) 119 (38) 0.0493 
Me&n gestational age at 
test (wks) (SD) 19.9 (3.l) 20.2 (2.9) 0.4303 
Gravidity.(t:nea:ll(SD)) 2.2 (l.5) 2.3 (1.6) 0.5432 
Prit:nigravidae (%) 42 (51) 142 (46) 0.4087 
Previous preterm 
labour(%) 30 (73) 122 (72) 0.8571 
Previous abortion(%) 19 (46) 80 (47) 0.9341 
Previous intra-uterine 
death(%) 9 (22) 64 (38) 0.0866 
Previous caesarean 
section(%) 8 (20) 25 (15) 0.4469 
Alcohol use(%) 18 (22) 27(9) 0.00089 
Cigarette smoking(%) 39 (47) 122 (39) 0.1938 
delivered before 37 weeks' gestation (40% v. 28%). Birth 
weights were significantly lower in the Mycoplasma group 
(Table II). Mean 5-minute Apgar scores, frequency of caesarean 
sections, neonatal intensive care unit (NICU) admissions, 
number of days in hospital and the number of neonatal deaths 
did not differ between the two groups (Table II). 
C. trachomatis and U. urealyticum occurred significantly more 
in the Mycoplasma group (Table III). Bacterial vaginosis was 
found in 75% of mothers where M. hominis was cultured from 
the vagina in contrast to the 22% when the organism was not 
found (odds ratio (OR) 10.21, 95% confidence interval (CI): 
5.63 - 18.65). Bacterial vaginosis was found in 71 % of 
primigravidae with positive cultures for M. hominis in contrast 
to the 22% when cultures were negative (OR 8.95, 95% 
Cl: 3.86 - 21.10). For multigravidae the frequency of bacterial 
vaginosis was 7.8% in the Mycoplasma-positive group in 
comparison to 23% in the Mycoplasma-negative group (OR 
11.94, 95% CI: 4.94 - 29.65). 
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Table II. Outcome of pregnancy in women in the Mycoplasma-
positive and negative groups 
Mycoplasma+ Mycoplasma- P-value 
Abortion ( < 22 weeks) 1 6 
Delivery < 37 weeks (%) 33 (40) 86 (28) 0.0313 
Mean gestational 
age (wks) (SD) 36.9 (3.4) 37.7 (2.7) 0.0409 
Mean Apgar score (SD) 9.3 (1.7) 9.5 (0.9) 0.2920 
Mean birth weight 
(g) (SD) 2669 (732) 2 864 (654) 0.0141 
Caesarean sections(%) 11 (13) 44 (14) 0.8425 
. NICU admission (%) 7 (9) 14 (5) 0.1215 
Mean days in 
hospital (SD) 4.9 (8.6) 4.1 (8.9) 0.4962 
Neonatal death 2 2 0.1941 
NICU ;:: neonatal intensive care unit. 
Table Ill. Other infections in women in the Mycoplasma-positive 
and negative groups 
Mycoplasma+ Mycoplasma- P-value 
Number of patients 83 312 
Chlamydia 
trachomatis (%) 15 (18) 25 (8) 0.0082 
Ureaplasma 
urealyticum (%) 80 (96) 252 (81) 0.0010 
Neisseria 
gonorrhoeae (%) 1 6 NS 
GroupB 
streptococcus(%) 10 (12) 27 (9) 0.3964 
Bacterial vaginosis (%) 62 (75) 70 (29) 0.00001 
OR 10.21 (95% 
CI: 5.63 - 18.65) 
DISCUSSION 
We found that M. hominis infection was associated with 
preterm labour. This confirms the finding of two previous 
studies at this institution.'-1°It also confirms the finding of 
Hillier et al.11 that preterm labour occurred more frequently 
among women with BV and M. hominis infections. In another 
study McGregor et al.1' also found that M. hominis was 
associated with both preterm labour and preterm birth. It also 
confirms the findings of an older study that this organism and 
U. urealyticum were associated with preterm labour.13 However, 
there are also findings suggesting the opposite. In an earlier 
study McGregor et al. 1' could not find a significant association 
between bacterial vaginosis, M. hominis infections and preterm 
birth or preterm rupture of membranes. A review of 12 studies, 
published in 1989, could not demonstrate an association 
between M. hominis and prematurity or low-birth-weight 
babies.15 These controversial findings may be partially the 
result of differences in study populations. The high repeat rate 
of preterm labour in mothers who had previous episodes of 
preterm labour or midtrimester miscarriage in our study may 
be due to the fact that we did not treat mothers with 
M. hominis infection. It is also possible that the BV is not 
directly involved in the causation of preterm labour but that it 
is only a marker of a more important underlying condition 
such as M. hominis infection, as among women with BV, the 
highest risk of preterm delivery was found among those with 
both vaginal bacteroides and M. hominis.11 Until more is known 
about the aetiology of repeated episodes of preterm labour, 
care should be taken when treating BV in these patients with 
metronidazole as a recent large randomised trial involving 
women with asymptomatic bacterial vaginosis did not show 
that treatment with metronidazole reduced the occurrence of 
preterm delivery.1• It has become necessary to assess whether 
treatment of M. hominis in pregnancy improves fetal and 
neonatal outcome. 
We wish to thank Jo-Ann Bannister for typing the manuscript 
and the Chief Medical Superintendent, Dr AK M M Rahman, for 
permission to publish. 
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